Good News | Shijiazhuang Xinji Technology Co., Ltd Officially Passes the Latest Veterinary GMP Acceptance

Recently, Shijiazhuang Xinji Technology Co., Ltd has successfully completed the on-site inspection and acceptance of the latest national Veterinary GMP standards. After one year of systematic preparation in strict adherence to high standards and stringent requirements, all seven applied dosage forms have obtained official certification, including eye drops, ear drops, topical ointments, tablets and granules, liquid non-chlorine disinfectants (Grade D Clean Area), and liquid topical insecticides (Grade D Clean Area).

The GMP inspection panel consists of experts from the Ministry of Agriculture and Rural Affairs, Hebei Provincial Department of Agriculture and Rural Affairs, and Hebei Provincial Veterinary Drug Supervision Institute. The panel carried out a thorough on-site inspection covering the company’s production workshops, quality inspection centers and warehousing systems, and conducted practical operation assessments as well as document audits for relevant professional staff.

Upon rigorous evaluation, the expert group unanimously confirmed that Xinji Biotechnology fully complies with the latest Veterinary GMP requirements in terms of plant premises and facilities, production technologies, quality control and management systems. High recognition was specially given to the company’s outstanding performance in risk control for shared production of multiple dosage forms, cleaning validation and data integrity management.

The expert team also commented that the company’s production equipment configuration has reached the domestic industry-leading level, laying a solid foundation for stable and upgraded product quality.

As a modern enterprise focusing on the full industrial chain of companion animal health, Xinji Biotechnology will assume greater social responsibility and boost the high-quality development of China’s pet health industry. Going forward, the company will further deepen strategic cooperation with VaxiAm (USA), Huapu Shijiazhuang Pharmaceutical Co., Ltd., Hebei Provincial Industrial Technology Research Institute of Compound Traditional Chinese Veterinary Medicine Preparations and other institutions. It will continuously optimize its product portfolio and quality management system to deliver superior solutions for all partners.

With the full commissioning and operation of GMP-compliant production lines, Xinji Biotechnology will further scale up its supply capacity of high-quality pet pharmaceuticals, provide solid support for the cause of companion animal health, and drive the standardized and regulated development of the whole industry.